Clinical Trial Update: Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults [NA]

View source ↗

Summary

Clinical trial update indicating Apatinib is being studied for recurrent atypical or malignant meningioma in adults; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Meningioma
• Malignant Meningioma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Beijing Sanbo Brain Hospital | Conditions: Recurrent Atypical/malignant Meningioma | NA | Status: RECRUITING